SCHEMBL14334646

SCHEMBL14334646

CC(C)(C)OC(=O)N1CCN(C2CCN(c3ncccc3[N+](=O)[O-])CC2)C(=O)C1

nearest known ligand 0.49

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.49
MAPT P10636 2/20 0.49
LMNA P02545 1/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 1/20 0.47
PRKCQ Q04759 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.45
GRM5 P41594 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
GPR119 Q8TDV5 2/20 0.44
POLB P06746 1/20 0.43
MET P08581 1/20 0.42
CRHBP P24387 1/20 0.42
CRHR2 Q13324 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14377498 0.95 ALDH1A1 (0.48) ALDH1A1MAPTLMNACYP1A2CYP2C9
SCHEMBL14335050 0.93 ALDH1A1 (0.48) ALDH1A1MAPTLMNACYP1A2CYP2C9
SCHEMBL29741462 0.84 CYP1A2 (0.59) ALDH1A1MAPTLMNACYP1A2CYP2C9
SCHEMBL3336130 0.84 CYP1A2 (0.59) ALDH1A1MAPTLMNACYP1A2CYP2C9
SCHEMBL14376986 0.81 GPR119 (0.44) GPR119POLB
SCHEMBL31343918 0.78 SMN1; SMN2 (0.62) ALDH1A1MAPTLMNACYP1A2CYP2C9
SCHEMBL14377500 0.78 GPR119 (0.47) GRM5GPR119POLB
SCHEMBL31013547 0.77 PRKCQ (0.52) ALDH1A1MAPTLMNACYP1A2CYP2C9
SCHEMBL14377209 0.76 CYP1A2 (0.62) ALDH1A1MAPTLMNACYP1A2CYP2C9
SCHEMBL14377365 0.76 ALDH1A1 (0.59) ALDH1A1MAPTLMNACYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012176123-A1 3 - IMIDAZOLYL- INDOLES FOR THE TREATMENT OF PROLIFERATIVE DISEASES NOVARTIS AG (CH) 2012-12-27 WO disclosed
WO-2012176123-A1 3 - IMIDAZOLYL- INDOLES FOR THE TREATMENT OF PROLIFERATIVE DISEASES NOVARTIS AG (CH) 2012-12-27 WO disclosed